While proponents of direct-to-consumer drug advertising tout them as vehicles for patient empowerment, critics point to their influence on unsound prescribing and the medicalization of human experience.
Naomi T. Laventhal, MD, MA, John D.E. Barks, MD, and Scott Y.H. Kim, MD, PhD
When considering off-label therapies in neonatal and pediatric patients, review available information about potential risks and benefits, carefully balance parental autonomy and the child's best interest, seek informed consent, and consider whether there is an opportunity to systematically evaluate the therapy.
Karen Uhlenhuth, Angira Patel, MD, and John Lantos, MD
A statin drug will not give a 10-year-old a high level of energy, the freedom to interact with peers without fear of being bullied, or a generally happy outlook on life.
All of us who are pursuing solutions to the obesity epidemic face clinical, ethical, and regulatory challenges. First among them is the significant role of individual lifestyle and behavior choices in causing obesity.
Lawrence J. Cheskin, MD, Scott Kahan, MD, MPH, and Gail Geller, ScD, MHS
Many health professionals harbor negative biases toward individuals who are obese. Cultivating an awareness of our own biases is the best way to avoid acting on them.
James Mills Jr., MD, a founder of emergency medicine, believed he could have greater impact on medical care for the poor in his city by giving up his practice and working in the emergency room full time.
The guidelines for patients’ eligibility for bariatric surgery have not changed since 1991, although recent data suggest there may be indications for broadening application of the surgery.